These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 15178499
1. Utilization of nonsteroidal anti-inflammatory drugs and antisecretory agents: a managed care claims analysis. Ofman JJ, Badamgarav E, Henning JM, Knight K, Laine L. Am J Med; 2004 Jun 15; 116(12):835-42. PubMed ID: 15178499 [Abstract] [Full Text] [Related]
9. A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea. Lee MC, Lee S, Suh DC, Kim J, Kong SX, Korea Arthritis Study Group. Curr Med Res Opin; 2003 Nov 15; 19(7):597-602. PubMed ID: 14606981 [Abstract] [Full Text] [Related]
10. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vargas R, Schnitzer TJ, Yu Q, Bombardier C. Gastroenterology; 2003 Feb 15; 124(2):288-92. PubMed ID: 12557133 [Abstract] [Full Text] [Related]
11. Persistence with COX-2 inhibitors in managed care: an analysis of claims data. Harley C, Wagner S. Manag Care Interface; 2003 Oct 15; 16(10):38-45. PubMed ID: 14606259 [Abstract] [Full Text] [Related]
12. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study. Moride Y, Ducruet T, Boivin JF, Moore N, Perreault S, Zhao S. Arthritis Res Ther; 2005 Oct 15; 7(2):R333-42. PubMed ID: 15743481 [Abstract] [Full Text] [Related]
14. Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population. Rahme E, Marentette MA, Kong SX, Lelorier J. Arthritis Rheum; 2002 Dec 15; 47(6):595-602. PubMed ID: 12522832 [Abstract] [Full Text] [Related]
15. Adverse Drug Events Involving COX-2 Inhibitors. Verrico MM, Weber RJ, McKaveney TP, Ansani NT, Towers AL. Ann Pharmacother; 2003 Sep 15; 37(9):1203-13. PubMed ID: 12921500 [Abstract] [Full Text] [Related]
16. Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin. Cheetham TC, Levy G, Niu F, Bixler F. Ann Pharmacother; 2009 Nov 15; 43(11):1765-73. PubMed ID: 19809010 [Abstract] [Full Text] [Related]
17. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Targownik LE, Metge CJ, Leung S, Chateau DG. Gastroenterology; 2008 Apr 15; 134(4):937-44. PubMed ID: 18294634 [Abstract] [Full Text] [Related]
18. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications. Pascucci RA. J Am Osteopath Assoc; 2002 Sep 15; 102(9):487-9. PubMed ID: 12361181 [Abstract] [Full Text] [Related]
20. Prescribing COX-2s for patients new to cyclo-oxygenase inhibition therapy. Cox ER, Motheral B, Frisse M, Behm A, Mager D. Am J Manag Care; 2003 Nov 15; 9(11):735-42. PubMed ID: 14626471 [Abstract] [Full Text] [Related] Page: [Next] [New Search]